Skip to main content
. 2013 Feb 20;168(5):1165–1181. doi: 10.1111/bph.12018

Figure 3.

Figure 3

Superoxide dismutative activity of copper-tobramycin measured as inhibition of the rate of nitro blue tetrazolium reduction. Copper-tobramycin potently inhibited NBT reduction with an IC50 of 200 nM. Tobramycin had no inhibitory effect at concentrations up to 500 μM.